Inventor
RUBIN MARK A
US19 patents
⚠️ This page may combine multiple inventors who share the name “RUBIN MARK A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MICHIGAN
4 patentsUS7718369B2May 18, 2010
Recurrent gene fusions in prostate cancer
UNIV MICHIGAN48 citations97
US7229774B2Jun 12, 2007
Expression profile of prostate cancer
UNIV MICHIGAN89 citations96
US7332290B2Feb 19, 2008
Dectection of AMACR cancer markers in urine
UNIV MICHIGAN36 citations88
US7767393B2Aug 3, 2010
Expression profile of prostate cancer
UNIV MICHIGAN4 citations61
TOMLINS SCOTT
4 patentsUS8211645B2Jul 3, 2012
Recurrent gene fusions in prostate cancer
TOMLINS SCOTT9 citations91
US9284609B2Mar 15, 2016
Recurrent gene fusions in prostate cancer
TOMLINS SCOTT3 citations82
US8580509B2Nov 12, 2013
Recurrent gene fusions in prostate cancer
TOMLINS SCOTT7 citations82
US8969527B2Mar 3, 2015
Recurrent gene fusions in prostate cancer
TOMLINS SCOTT1 citations61
RUBIN MARK A
4 patentsUS9090899B2Jul 28, 2015
Methods of diagnosing and treating prostate cancer characterized by NDRG1-ERG fusion
RUBIN MARK A2 citations51
US10443102B2Oct 15, 2019
Recurrent SPOP mutations in prostate cancer
RUBIN MARK A0 citations40
US9568483B2Feb 14, 2017
Molecular subtyping, prognosis and treatment of prostate cancer
RUBIN MARK A0 citations40
US9458213B2Oct 4, 2016
Compositions and methods for diagnosing prostate cancer based on detection of SLC45A3-ELK4 fusion transcript
RUBIN MARK A0 citations40
BRIGHAM & WOMENS HOSPITAL
3 patentsUS7981609B2Jul 19, 2011
Methods for identifying and using SNP panels
BRIGHAM & WOMENS HOSPITAL61 citations96
US7666595B2Feb 23, 2010
Biomarkers for predicting prostate cancer progression
BRIGHAM & WOMENS HOSPITAL11 citations83
US7803552B2Sep 28, 2010
Biomarkers for predicting prostate cancer progression
BRIGHAM & WOMENS HOSPITAL1 citations51